摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-fluoro-6-(2-thiomorpholin-4-ylethoxy)quinoline-3-carbonitrile | 1004994-58-4

中文名称
——
中文别名
——
英文名称
4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-fluoro-6-(2-thiomorpholin-4-ylethoxy)quinoline-3-carbonitrile
英文别名
——
4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-fluoro-6-(2-thiomorpholin-4-ylethoxy)quinoline-3-carbonitrile化学式
CAS
1004994-58-4
化学式
C26H24ClFN6OS2
mdl
——
分子量
555.1
InChiKey
RZPPFDDTLKTKHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    130
  • 氢给体数:
    1
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    哌啶4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-fluoro-6-(2-thiomorpholin-4-ylethoxy)quinoline-3-carbonitrileN-甲基吡咯烷酮 、 sodium iodide 作用下, 以77%的产率得到4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-piperidin-1-yl-6-(2-thiomorpholin-4-ylethoxy)quinoline-3-carbonitrile
    参考文献:
    名称:
    Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors
    摘要:
    We have previously reported on a series of 4-anilino-6,7-dialkoxy-3-quinolinecarbonitriles as potent inhibitors of MEK1 kinase. Herein, we describe our synthetic efforts toward a series of 4-anilino-6-allcoxy-7-amino-3-quinolinecarbonitriles. In the course of this work, we were able to rapidly construct a library of 4-anilino-6-alkoxy-7-amino-3-quinolinecarbonitriles by simultaneous or sequential S(N)2 (displacement) reactions on the C-6 chloroalkoxy moiety and SNAr (addition/elimination) reactions at C-7 with nucleophilic amines. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2007.10.151
  • 作为产物:
    描述:
    硫代吗啉6-(2-Chloroethoxy)-4-[3-chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-fluoroquinoline-3-carbonitrileN-甲基吡咯烷酮 、 sodium iodide 作用下, 以54%的产率得到4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-7-fluoro-6-(2-thiomorpholin-4-ylethoxy)quinoline-3-carbonitrile
    参考文献:
    名称:
    Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors
    摘要:
    We have previously reported on a series of 4-anilino-6,7-dialkoxy-3-quinolinecarbonitriles as potent inhibitors of MEK1 kinase. Herein, we describe our synthetic efforts toward a series of 4-anilino-6-allcoxy-7-amino-3-quinolinecarbonitriles. In the course of this work, we were able to rapidly construct a library of 4-anilino-6-alkoxy-7-amino-3-quinolinecarbonitriles by simultaneous or sequential S(N)2 (displacement) reactions on the C-6 chloroalkoxy moiety and SNAr (addition/elimination) reactions at C-7 with nucleophilic amines. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2007.10.151
点击查看最新优质反应信息

文献信息

  • Observation of differential reactivity of cyclic amines in SN2 and SNAr displacement reactions in the course of synthesizing C-6, C-7 substituted quinolinecarbonitrile MEK1 kinase inhibitors
    作者:Darrin W. Hopper、Minu Dutia、Dan M. Berger、Dennis W. Powell
    DOI:10.1016/j.tetlet.2007.10.151
    日期:2008.1
    We have previously reported on a series of 4-anilino-6,7-dialkoxy-3-quinolinecarbonitriles as potent inhibitors of MEK1 kinase. Herein, we describe our synthetic efforts toward a series of 4-anilino-6-allcoxy-7-amino-3-quinolinecarbonitriles. In the course of this work, we were able to rapidly construct a library of 4-anilino-6-alkoxy-7-amino-3-quinolinecarbonitriles by simultaneous or sequential S(N)2 (displacement) reactions on the C-6 chloroalkoxy moiety and SNAr (addition/elimination) reactions at C-7 with nucleophilic amines. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多